Mirae Asset Global Etfs Holdings Ltd. Cerevel Therapeutics Holdings, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 42,761 shares of CERE stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,761Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CERE
# of Institutions
147Shares Held
127MCall Options Held
1.91MPut Options Held
2.7M-
Perceptive Advisors LLC New York, NY10.8MShares$012.77% of portfolio
-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
State Street Corp Boston, MA3.11MShares$00.01% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.33MShares$03.86% of portfolio
-
George Soros Soros Fund Management LLC | New York, Ny2.15MShares$02.16% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...